People · Operator
Named in public records as an officer, director or promoter · active 2013–2018 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Oncopia Therapeutics, LLC | — | Biotechnology | Series A | $8.4M | $54.2M | 2017 |
| OncoFusion Therapeutics, Inc. | — | Other Health Care | Pre-Seed | $525K | $16.2M | 2013 |
Shaomeng Wang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Shaomeng Wang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| J. Mel Sorensen | 1 | 3 |
| Brian Mel Wood | 1 | 2 |
| Eric Qun Zhao | 1 | 1 |
| Mel Sorensen, M.D. | 1 | 1 |
| Peter Sugar | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.